Home
Home
  • Home
  • About Us About Us
    • Overview
    • Who we are
    • Why we provide advice
    • What are health technologies
    • Meetings
    • News
    • Who we work with
    • Contact Us
  • What We Do What We Do
    • Overview
    • Our Strategy
    • Work programme
    • Range of advice products
    • Quarterly Bulletin of advice
    • Early HTA Advice Service
  • Our Advice
  • Request Advice Request Advice
    • Overview
    • Form for requesting advice
  • Get Involved Get Involved
    • Overview
    • Contribute to advice
    • NHS boards
    • Patient and Public Involvement
    • Industry Involvement
    • Observe a council meeting
    • DOI Form

Advice Statement

  • Home
  • Our Advice
  • Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults who are not eligible for surgery

Title

Output Type

Speciality

Published

Title

Transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults who are not eligible for surgery

Output Type

Advice Statement

Speciality

Cardiovascular System

Published

1 April 2014

Recommendation for NHSScotland

  • Despite remaining uncertainty over cost effectiveness and the safety issues associated with the use of TAVI in patients ineligible for surgery, the evidence of clinical benefit supports the use of TAVI for inoperable patients and the ongoing collection of patient selection and outcome data.
  • TAVI technology continues to evolve. Rapid progress is being made in device modification and patient selection such that the published evidence base may not fully capture the emergent evidence for the latest generation of TAVI devices.
  • The National Planning Forum TAVI expert review and clinical oversight groups will continue to monitor the operation and outcomes of the national TAVI service.

NHSScotland is required to consider the Scottish Health Technologies Group (SHTG) advice.

What were we asked to look at?

Clinical and cost effectiveness of transcatheter aortic valve implantation (TAVI) for severe symptomatic aortic stenosis in adults who are not eligible for surgery.

Referred by

National Planning Forum TAVI Review Group

Download icon
Download Advice
pdf (156 KB)
Download icon
Download Evidence Note
pdf (2 MB)

Connect with Us

Please let us know if you'd like to receive regular updates on our work.


Last Updated: 31 January 2022

Scottish Health Technologies Group

© 2021, All rights reserved

  • Accessibility
  • Respecting your privacy
  • Cookies
  • Healthcare Improvement Scotland Website
  • Find us on Twitter
  • Freedom of Information

Tell us what you think


We'd love to hear your views

Was our advice useful?  Did you find what you were looking for on our website?